-

Bioceres Crop Solutions to Participate in the 35th Annual Roth Conference

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, will participate in the 35th Annual Roth Conference scheduled for March 12-14, 2023 to be held at The Ritz Carlton Laguna Niguel in Dana Point, California.

Bioceres Chief Executive Officer Federico Trucco and Chief Financial Officer Enrique Lopez Lecube will attend the event in-person where they will conduct one-on-one meetings to discuss the Company’s recently announced fiscal second quarter 2023 financial results, as well as HB4 Wheat 2022/23 results and recent progress on regulatory approvals.

Chief Executive Officer Federico Trucco will also participate in the “AG Biologicals and Gene Editing” panel scheduled for Monday, March 13 at 1:30 PM PT.

35th Annual Roth Conference
Date: March 12-14, 2023
Format: In-person one-on-one meetings and panel presentation
Attendees: Chief Executive Officer Federico Trucco, and Chief Financial Officer Enrique Lopez Lecube
Conference Website: Click here

For more information on the conference, please contact your ROTH representative.

About Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4 program, the Company is bringing digital solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more information, visit here.

Contacts

Bioceres Crop Solutions
Paula Savanti
Head of Investor Relations
investorrelations@biocerescrops.com

Bioceres Crop Solutions Corp.

NASDAQ:BIOX

Release Versions

Contacts

Bioceres Crop Solutions
Paula Savanti
Head of Investor Relations
investorrelations@biocerescrops.com

More News From Bioceres Crop Solutions Corp.

CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--The dial-in details of release dated May 4, 2026 have been revised. The US Toll Free dial-in number should read 1-833-461-5787; the International dial-in numbers link has been updated; and the Conference ID: should read 717574163. The updated release reads: BIOCERES CROP SOLUTIONS TO HOST FISCAL THIRD QUARTER 2026 FINANCIAL RESULTS CONFERENCE CALL ON TUESDAY, MAY 12, 2026 AT 8:30 A.M. EASTERN TIME Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or t...

A Message from Our Chief Executive Officer

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX): Dear Fellow Shareholders, This communication accompanies the filing of our Form 6-K for the second quarter of fiscal year 2026, covering the six-month period ended 31 December 2025. I want to speak directly to our shareholders about where we stand, what we are focused on, and how we are navigating a period that has been both challenging and clarifying for Bioceres. OUR CONTINUING BUSINESS — FOCUS AND DIRECTION Th...

Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons...
Back to Newsroom